Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Samsung BioLogics

Division of Samsung Electronics Co. Ltd.
www.samsungbiologics.com

Latest From Samsung BioLogics

Samsung Bioepis Targets Brazil With Brenzys

Samsung Bioepis has entered a fifth continent by launching its Brenzys etanercept biosimilar in Brazil, as part of global expansion plans for the business.

Biosimilars Launches

Samsung Bioepis Gets US Adalimumab Nod

Samsung Bioepis has become the first company to receive FDA approvals for biosimilars of all three first-generation anti-TNF biologics after gaining a nod for its Hadlima biosimilar adalimumab.

Biosimilars Regulation

Samsung Bioepis’ Adalimumab Has A Longer Life Out Of The Fridge

Samsung Bioepis’ Imraldi adalimumab biosimilar has been granted a European label update that approves the product to be stored in non-refrigerated conditions for up to 28 days.

Biosimilars Regulation

Biogen’s Henshaw Insists Data Is Key In Bolstering Biosimilars

Data published by Biogen is a key factor in driving uptake and acceptance of its biosimilars, the firm’s head of biosimilars, Ian Henshaw, told Generics Bulletin in an exclusive interview.

Biosimilars Europe
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
  • Services
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Samsung-Quintiles joint venture
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • South Korea
  • Parent & Subsidiaries
  • Samsung Electronics Co. Ltd.
  • Senior Management
  • Tae Han Kim, PhD, CEO
    Dongjoong Kim, CFO
  • Contact Info
  • Samsung BioLogics
    Phone: 2 2255 8500
    300 Songdo Bio Way
    Yeonsu-gu
    Incheon, 21987
    South Korea
Advertisement
Advertisement
UsernamePublicRestriction

Register